Edgar Lomax Company’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Sell
216,815
-19,430
-8% -$1.57M 1.37% 29
2026
Q1
$16.7M Buy
236,245
+16,835
+8% +$1.26M 1.19% 38
2025
Q4
$17.3M Sell
219,410
-5,005
-2% -$396K 1.32% 34
2025
Q3
$18.5M Sell
224,415
-65,585
-23% -$5.16M 1.45% 28
2025
Q2
$23.3M Sell
290,000
-4,605
-2% -$355K 1.48% 28
2025
Q1
$23.7M Buy
294,605
+140,855
+92% +$11.7M 1.48% 28
2024
Q4
$12.6M Sell
153,750
-2,935
-2% -$244K 0.81% 41
2024
Q3
$12.9M Sell
156,685
-2,470
-2% -$185K 0.79% 45
2024
Q2
$11.2M Sell
159,155
-2,855
-2% -$204K 0.72% 46
2024
Q1
$12M Buy
+162,010
New +$11.3M 0.74% 46
2023
Q1
Sell
-1,048,191
Closed -$75.9M 65
2022
Q4
$75.9M Sell
1,048,191
-6,295
-0.6% -$451K 4.6% 5
2022
Q3
$64.1M Sell
1,054,486
-237,695
-18% -$15.2M 4.43% 4
2022
Q2
$81.1M Buy
1,292,181
+26,030
+2% +$1.72M 5.08% 3
2022
Q1
$89M Sell
1,266,151
-122,830
-9% -$8.3M 5.22% 1
2021
Q4
$86.8M Sell
1,388,981
-13,210
-0.9% -$829K 5.2% 2
2021
Q3
$86.6M Sell
1,402,191
-32,660
-2% -$1.97M 5.55% 1
2021
Q2
$85.9M Sell
1,434,851
-46,650
-3% -$2.96M 5.34% 1
2021
Q1
$90.1M Sell
1,481,501
-74,955
-5% -$4.14M 5.61% 1
2020
Q4
$73.1M Sell
1,556,456
-27,700
-2% -$1.2M 4.97% 2
2020
Q3
$58.9M Buy
1,584,156
+67,850
+4% +$2.58M 4.54% 4
2020
Q2
$55.4M Buy
1,516,306
+31,465
+2% +$1.1M 4.43% 6
2020
Q1
$45.4M Buy
1,484,841
+1,265,850
+578% +$56.1M 4.03% 7
2019
Q4
$11.2M Sell
218,991
-5,200
-2% -$251K 0.72% 39
2019
Q3
$10.6M Sell
224,191
-2,300
-1% -$110K 0.71% 42
2019
Q2
$11.3M Sell
226,491
-3,150
-1% -$148K 0.77% 39
2019
Q1
$9.78M Buy
229,641
+45,050
+24% +$1.99M 0.67% 48
2018
Q4
$7.58M Sell
184,591
-2,000
-1% -$85.8K 0.58% 50
2018
Q3
$8.72M Sell
186,591
-6,500
-3% -$297K 0.59% 50
2018
Q2
$8.42M Buy
193,091
+1,500
+0.8% +$69.9K 0.59% 53
2018
Q1
$8.79M Buy
191,591
+35,400
+23% +$1.72M 0.63% 47
2017
Q4
$7.9M Sell
156,191
-4,615
-3% -$243K 0.54% 49
2017
Q3
$8.35M Sell
160,806
-34,975
-18% -$1.7M 0.59% 48
2017
Q2
$9.59M Sell
195,781
-5,470
-3% -$254K 0.66% 45
2017
Q1
$9.47M Buy
201,251
+33,157
+20% +$1.58M 0.63% 46
2016
Q4
$8.07M Sell
168,094
-13,791
-8% -$633K 0.52% 44
2016
Q3
$7.2M Buy
181,885
+112
+0.1% +$4.21K 0.45% 51
2016
Q2
$6.45M Buy
181,773
+9,041
+5% +$353K 0.4% 52
2016
Q1
$6.76M Buy
172,732
+15,989
+10% +$598K 0.46% 51
2015
Q4
$6.74M Buy
+156,743
New +$6.89M 0.49% 49

Other funds holding MET

Edgar Lomax Company's MET Position: Q2 2026 in Review

Edgar Lomax Company reduced its MetLife (MET) stake by 8.2% in Q2 2026, selling an estimated $1.57M and leaving 216,815 shares worth $18.3M. The position accounts for 1.37% of the portfolio, ranked #29.

Edgar Lomax Company first reported a position in MET in Q4 2015 and has held it in 39 quarters since. The position peaked at $90.1M in Q1 2021. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Edgar Lomax Company held 216,815 shares of MetLife worth $18.3M as of Q2 2026.
  • Edgar Lomax Company sold 19,430 MetLife shares in Q2 2026, an estimated $1.57M.
  • MetLife made up 1.37% of Edgar Lomax Company's portfolio in Q2 2026, its #29 holding.
  • Edgar Lomax Company first reported a position in MetLife in Q4 2015 and has held it in 39 quarters since.
  • Edgar Lomax Company's MetLife position peaked at $90.1M in Q1 2021.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Edgar Lomax Company's 13F filing for Q2 2026, filed 13 Aug 2026.